Spdr S&P Pharmaceuticals Etf
Eli Lilly’s Breakthrough Weight Loss Drug Triumphs in Key Obesity Trial: What This Means for You
Eli Lilly has made exciting strides in the fight against obesity with its new drug, retatrutide. This medication just passed ... Read more
Novo Nordisk Shares Drop 15% as Weight Loss Drug Fails to Compete with Eli Lilly’s Breakthrough in Latest Trial
Novo Nordisk’s stock dropped by 15% on Monday after news that its weight-loss drug, CagriSema, did not meet its main ... Read more
